Ranibizumab Intraocular and Tacrolimus Extended-Release Tablets
Determining the interaction of Ranibizumab Intraocular and Tacrolimus Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Tacrolimus Granules for Suspension
- Ranibizumab Intraocular-Tacrolimus Injection
- Ranibizumab Intraocular-Tacrolimus Intravenous
- Ranibizumab Intraocular-Tacrolimus oral and injection
- Ranibizumab Intraocular-Tacrolimus Oral, Intravenous
- Ranibizumab Intraocular-Tactinal
- Tacrolimus Extended-Release Tablets-Ranibizumab ophthalmic
- Tacrolimus Extended-Release Tablets-Ranitidine
- Tacrolimus Extended-Release Tablets-Ranitidine Capsule
- Tacrolimus Extended-Release Tablets-Ranitidine Hydrochloride
- Tacrolimus Extended-Release Tablets-Ranitidine Injection
- Tacrolimus Extended-Release Tablets-Ranitidine Suspension